However, another recent study showed that high expression of IL6+ immune cells within the stroma and invasive front of CRC tumours was associated with favourable clinical characteristics and better survival outcomes in early-stage disease (n = 153) [12]. The gene discussed is IL6; the disease is colorectal carcinoma.